References
- Adelman M.W., Woodworth M.H., Langelier C., Busch L.M., Kempker J.A., Kraft C.S., & Martin G.S.: The gut microbiome’s role in the development, maintenance, and outcomes of sepsis. Crit. Care, 24, 1–10 (2020)
- Brandt J.S., Hadaya O., Schuster M., Rosen T., Sauer M.V., & Ananth C.V.: A bibliometric analysis of top-cited journal articles in obstetrics and gynecology. JAMA Netw. Open 2, e1918007 (2019)
- Cheema H.A., Shahid A., Ayyan M., Mustafa B., Zahid A., Fatima M., Ehsan M., Athar F., Duric N., & Szakmany T.: Probiotics for the prevention of ventilator-associated pneumonia: An updated systematic review and meta-analysis of randomized controlled trials. Nutrients 14, 8 (2022)
- Chin V.K., Yong V.C., Chong P.P., Nordin S.A., Basir R., & Abdullah M.: Mycobiome in the gut: A multiperspective review. Mediators Inflamm. 2020, 9560684 (2020)
- Condotta S.A., Cabrera-Perez J., Badovinac V.P., & Griffith T.S.: T-cell-mediated immunity and the role of TRAIL in sepsisinduced immunosuppression. Crit. Rev. Immunol. 33, 23–40 (2013)
- Coopersmith C.M., et al.: Surviving sepsis campaign: research priorities for sepsis and septic shock. Intensive Care Med. 44, 1400–1426 (2018)
- Cresci G.A. & Bawden E.: Gut microbiome: What we do and don’t know. Nutr. Clin. Pract. 30, 734–746 (2015)
- Dubin K.A.: Microbial dynamics during gut inflammation and infection. Weill Medical College of Cornell University (2018)
- Haak B.W. & Wiersinga W.J.: The role of the gut microbiota in sepsis. Lancet Gastroenterol. Hepatol. 2, 135–143 (2017)
- He D., Wang H.Y., Feng J.Y., Zhang M.M., Zhou Y., & Wu X.T.: Use of pro-/synbiotics as prophylaxis in patients undergoing colorectal resection for cancer: A meta-analysis of randomized controlled trials. Clin. Res. Hepatol. Gastroenterol. 37, 406–415 (2013)
- Heintz-Buschart A., Wilmes P.: Human Gut Microbiome: Function Matters. Trends Microbiol. 26(7), 563–574 (2018)
- Hills R.D. Jr, Pontefract B.A., Mishcon H.R., Black C.A., Sutton S.C., Theberge C.R.: Gut Microbiome: Profound Implications for Diet and Disease. Nutrients. 11(7), 1613 (2019)
- Jandhyala S.M., Talukdar R., Subramanyam C., Vuyyuru H., Sasikala M., Nageshwar Reddy D.: Role of the normal gut microbiota. World J Gastroenterol. 21(29) 8787–8803 (2015)
- Jawhara S.: How gut bacterial dysbiosis can promote Candida albicans overgrowth during colonic inflammation. Microorganisms 10, 1014 (2022)
- Johnstone J. & Zytaruk N. et al.: Effect of probiotics on incident ventilator-associated pneumonia in critically ill patients: A randomized clinical trial. JAMA, 326, 1024–1033 (2021)
- Kullberg R.F., Wiersinga W.J., & Haak B.W.: Gut microbiota and sepsis: From pathogenesis to novel treatments. Curr. Opin. Gastroenterol. 37, 578–585 (2021)
- Liu Y.C., Yao Y., Yu M.M., Gao Y.L., Qi A.L., Jiang T.Y., Chen Z.S., Shou S.T., & Chai Y.F.: Frequency and mortality of sepsis and septic shock in China: A systematic review and metaanalysis. BMC Infect. Dis. 22, 564 (2022)
- Miller W.D., Keskey R., & Alverdy J.C.: Sepsis and the microbiome: A vicious cycle. J. Infect. Dis. 223, S264-S269 (2021)
- Ramirez J., Guarner F., Bustos Fernandez L., Maruy A., Sdepanian V.L., & Cohen H.: Antibiotics as major disruptors of gut microbiota. Front. Cell Infect. Microbiol. 10, 572912 (2020)
- Rhee C. & Clompas M. et al.: Incidence and trends of sepsis in US hospitals using clinical vs claims data, 2009–2014. JAMA 318(13), 1241–1249 (2017)
- Schmidt T.S.B., Raes J., & Bork P.: The human gut microbiome: From association to modulation. Cell 172, 1198–1215 (2018)
- Shimizu K. & Sugimoto H. et al.: Altered gut flora are associated with septic complications and death in critically ill patients with systemic inflammatory response syndrome. Dig. Dis. Sci. 56, 1171–1177 (2011)
- Singer M. & Deutschman C.S. et al.: The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 315, 801–810 (2016)
- Tourelle K.M., Boutin S., Weigand M.A., & Schmitt F.C.: Sepsis and the human microbiome: Just another kind of organ failure? A review. J. Clin. Med. 10, 4831 (2021)
- Wang J.W., Kuo C.H., Kuo F.C., Wang Y.K., Hsu W.H., Yu F.J., Hu H.M., Hsu P.I., Wang J.Y., & Wu D.C.: Fecal microbiota transplantation: Review and update. J. Formos. Med. Assoc. 118, S23-S31 (2019)
- Wiersinga W.J. & van der Poll T.: Immunopathophysiology of human sepsis. E.Bio.Medicine. 86, 104363 (2022)
- Wu F., Gao J., Kang J., Wang X., Niu Q., Liu J., & Zhang L.: Knowledge mapping of exosomes in autoimmune diseases: A bibliometric analysis (2002–2021). Front. Immunol. 13, 939433 (2022)
- Wu T., Wu Y., Nie K., Yan J., Chen Y., Wang S., & Zhang J.: Bibliometric analysis and global trends in uterus transplantation. Int. J. Surg. 110, 4932–4946 (2024)
- Zanza C., Romenskaya T., Thangathurai D., Ojetti V., Saviano A., Abenavoli L., Robba C., Cammarota G., Franceschi F., & Piccioni A.: Microbiome in critical care: An unconventional and unknown ally. Curr. Med. Chem. 29, 3179–3188 (2022)